Literature DB >> 12393603

Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10.

Dominique Berrebi1, Stefano Bruscoli, Nicolas Cohen, Arnaud Foussat, Graziella Migliorati, Laurence Bouchet-Delbos, Marie-Christine Maillot, Alain Portier, Jacques Couderc, Pierre Galanaud, Michel Peuchmaur, Carlo Riccardi, Dominique Emilie.   

Abstract

Glucocorticoids and interleukin 10 (IL-10) prevent macrophage activation. In murine lymphocytes, glucocorticoids induce expression of glucocorticoid-induced leucine zipper (GILZ), which prevents the nuclear factor kappaB (NF-kappaB)-mediated activation of transcription. We investigated whether GILZ could account for the deactivation of macrophages by glucocorticoids and IL-10. We found that GILZ was constitutively produced by macrophages in nonlymphoid tissues of humans and mice. Glucocorticoids and IL-10 stimulated the production of GILZ by macrophages both in vitro and in vivo. Transfection of the macrophagelike cell line THP-1 with the GILZ gene inhibited the expression of CD80 and CD86 and the production of the proinflammatory chemokines regulated on activation normal T-cell expressed and secreted (CCL5) and macrophage inflammatory protein 1alpha (CCL3). It also prevented toll-like receptor 2 production induced by lipopolysaccharide, interferongamma, or an anti-CD40 mAb, as well as NF-kappaB function. In THP-1 cells treated with glucocorticoids or IL-10, GILZ was associated with the p65 subunit of NF-kappaB. Activated macrophages in the granulomas of patients with Crohn disease or tuberculosis do not produce GILZ. In contrast, GILZ production persists in tumor-infiltrating macrophages in Burkitt lymphomas. Therefore, GILZ appears to play a key role in the anti-inflammatory and immunosuppressive effects of glucocorticoids and IL-10. Glucocorticoid treatment stimulates GILZ production, reproducing an effect of IL-10, a natural anti-inflammatory agent. The development of delayed-type hypersensitivity reactions is associated with the down-regulation of GILZ gene expression within lesions. In contrast, the persistence of GILZ gene expression in macrophages infiltrating Burkitt lymphomas may contribute to the failure of the immune system to reject the tumor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12393603     DOI: 10.1182/blood-2002-02-0538

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  80 in total

1.  Lack of glucocorticoid-induced leucine zipper (GILZ) deregulates B-cell survival and results in B-cell lymphocytosis in mice.

Authors:  Stefano Bruscoli; Michele Biagioli; Daniele Sorcini; Tiziana Frammartino; Monica Cimino; Paolo Sportoletti; Emanuela Mazzon; Oxana Bereshchenko; Carlo Riccardi
Journal:  Blood       Date:  2015-08-14       Impact factor: 22.113

2.  Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases.

Authors:  H Schäcke; T M Zollner; W D Döcke; H Rehwinkel; S Jaroch; W Skuballa; R Neuhaus; E May; U Zügel; K Asadullah
Journal:  Br J Pharmacol       Date:  2009-05-06       Impact factor: 8.739

Review 3.  Directing dendritic cell immunotherapy towards successful cancer treatment.

Authors:  Rachel Lubong Sabado; Nina Bhardwaj
Journal:  Immunotherapy       Date:  2010-01       Impact factor: 4.196

Review 4.  Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases.

Authors:  Ilse M E Beck; Wim Vanden Berghe; Linda Vermeulen; Keith R Yamamoto; Guy Haegeman; Karolien De Bosscher
Journal:  Endocr Rev       Date:  2009-11-04       Impact factor: 19.871

Review 5.  Cellular and molecular regulation of innate inflammatory responses.

Authors:  Juan Liu; Xuetao Cao
Journal:  Cell Mol Immunol       Date:  2016-10-31       Impact factor: 11.530

6.  Crosstalk between bone marrow-derived mesenchymal stem cells and regulatory T cells through a glucocorticoid-induced leucine zipper/developmental endothelial locus-1-dependent mechanism.

Authors:  Nianlan Yang; Babak Baban; Carlos M Isales; Xing-Ming Shi
Journal:  FASEB J       Date:  2015-06-02       Impact factor: 5.191

7.  Microglial Homeostasis Requires Balanced CSF-1/CSF-2 Receptor Signaling.

Authors:  Violeta Chitu; Fabrizio Biundo; Gabriel G L Shlager; Eun S Park; Ping Wang; Maria E Gulinello; Şölen Gokhan; Harmony C Ketchum; Kusumika Saha; Michael A DeTure; Dennis W Dickson; Zbignew K Wszolek; Deyou Zheng; Andrew L Croxford; Burkhard Becher; Daqian Sun; Mark F Mehler; E Richard Stanley
Journal:  Cell Rep       Date:  2020-03-03       Impact factor: 9.423

8.  Glucocorticoid-induced leucine zipper (GILZ) promotes the nuclear exclusion of FOXO3 in a Crm1-dependent manner.

Authors:  Perle Latré de Laté; Aurélie Pépin; Hind Assaf-Vandecasteele; Christophe Espinasse; Valérie Nicolas; Marie-Liesse Asselin-Labat; Jacques Bertoglio; Marc Pallardy; Armelle Biola-Vidamment
Journal:  J Biol Chem       Date:  2009-12-14       Impact factor: 5.157

9.  Induction of Glucocorticoid-induced Leucine Zipper (GILZ) Contributes to Anti-inflammatory Effects of the Natural Product Curcumin in Macrophages.

Authors:  Jessica Hoppstädter; Nina Hachenthal; Jenny Vanessa Valbuena-Perez; Sebastian Lampe; Ksenia Astanina; Michael M Kunze; Stefano Bruscoli; Carlo Riccardi; Tobias Schmid; Britta Diesel; Alexandra K Kiemer
Journal:  J Biol Chem       Date:  2016-09-14       Impact factor: 5.157

10.  Identification of glucocorticoid-induced leucine zipper as a key regulator of tumor cell proliferation in epithelial ovarian cancer.

Authors:  Nassima Redjimi; Françoise Gaudin; Cyril Touboul; Dominique Emilie; Marc Pallardy; Armelle Biola-Vidamment; Hervé Fernandez; Sophie Prévot; Karl Balabanian; Véronique Machelon
Journal:  Mol Cancer       Date:  2009-10-08       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.